CDK12 and Ewing sarcoma: Likewise, inhibition of CDK12 resulted in synthetic lethality in Ewing sarcomas driven by the oncogenic fusion protein EWS‐FLI1 [177], which encodes for a powerful transcription factor that reprogrammes the transcriptome of sarcoma cells [178].